John Patrick Donohue

John Patrick Donohue's AcademicInfluence.com Rankings

Philosophy

#8077

World Rank

#11390

Historical Rank

Logic

#5108

World Rank

#6472

Historical Rank

philosophy Degrees

Download Badge

Philosophy

John Patrick Donohue's Degrees

Doctorate Medicine University of California, San Francisco

Why Is John Patrick Donohue Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John Patrick Donohue's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. (1977) (1487)
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. (1999) (489)
Primary aldosteronism: diagnosis, localization, and treatment. (1979) (328)
Distribution of nodal metastases in nonseminomatous testis cancer. (1982) (319)
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. (1987) (287)
Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. (1990) (275)
Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. (1993) (255)
Late relapse of testicular cancer. (1995) (237)
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. (1995) (235)
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. (1993) (199)
Surgical salvage of chemorefractory germ cell tumors. (1993) (197)
Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction (1981) (192)
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee (2011) (186)
Complications of post-chemotherapy retroperitoneal lymph node dissection. (1995) (177)
Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989. (1993) (176)
Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. (1987) (172)
Improved chemotherapy in disseminated testicular cancer. (1977) (166)
Complications of primary retroperitoneal lymph node dissection. (1994) (165)
Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node Dissection (1995) (158)
The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). (1995) (153)
High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. (1994) (137)
Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. (1986) (133)
High-intensity focused ultrasound in the treatment of prostatic disease. (1993) (131)
Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. (1997) (120)
Complications of retroperitoneal lymph node dissection. (1981) (112)
Integration of surgery and systemic therapy: results and principles of integration. (1998) (109)
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? (2007) (108)
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer. (2000) (108)
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? (2003) (106)
Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. (2004) (103)
Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. (1991) (103)
Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. (1995) (99)
Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent. (1980) (97)
Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer. (1993) (94)
Combination chemotherapy in disseminated testicular cancer: the Indiana University experience. (1979) (92)
Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. (1982) (91)
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. (2000) (91)
Adult primary pure teratoma of the testis. The Indiana experience (1995) (90)
Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection. (1995) (88)
Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. (1996) (87)
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. (2005) (87)
Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors. (1982) (81)
Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques. (1998) (80)
Does retroperitoneal lymph node dissection have a curative role for patients with sex cord–stromal testicular tumors? (2003) (78)
Late relapse of clinical stage I testicular cancer. (1995) (77)
Surgical anatomy of the lumbar vessels: implications for retroperitoneal surgery. (1995) (75)
Improved management of nonseminomatous testis tumors (1978) (74)
Cutaneous Inflammatory Disorder in Integrin αE (CD103)-Deficient Mice1 (2000) (72)
Immediate Adjuvant Chemotherapy Versus Observation With Treatment at Relapse in Pathological Stage II Testicular Cancer (1988) (68)
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor (1997) (68)
Comparison of NMR and CT Imaging in the Evaluation of Metastatic Retroperitoneal Lymphadenopathy from Testicular Carcinoma (1984) (59)
Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. (2001) (59)
Teratoma in the Orchiectomy Specimen and Volume of Metastasis are Predictors of Retroperitoneal Teratoma in Post-Chemotherapy Nonseminomatous Testis Cancer (1996) (59)
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment. (1998) (58)
Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer. (1984) (58)
Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. (1994) (57)
Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan). (1979) (56)
Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. (2000) (55)
Germ cell tumor associated primitive neuroectodermal tumors. (2001) (55)
High-intensity focused ultrasound in the treatment of prostatic tissue. (1994) (54)
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers. (1996) (53)
Improved management of non-seminomatous testis tumors. (1979) (52)
The significance of atypia within teratomatous metastases after chemotherapy for malignant germ cell tumors (1987) (52)
Bilateral testicular tumors (1998) (52)
Renal Vascular Hypertension (1986) (52)
The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection. (1994) (52)
Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound. (1993) (50)
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group. (1997) (49)
Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma? (1998) (49)
The importance of one-stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. (1983) (49)
Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience. (2000) (49)
En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. (1998) (49)
Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. (1993) (48)
Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. (1998) (48)
Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases (1990) (47)
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. (1996) (47)
Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection. (2001) (45)
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. (2007) (44)
Histology in mixed germ cell tumors. Is there a favorite pairing? (2004) (43)
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. (2002) (43)
Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology. (1998) (42)
Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings. (1995) (41)
Nerve-sparing retroperitoneal lymphadenectomy. (1990) (40)
Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors. (1996) (39)
Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma. (1994) (38)
Resection of the inferior vena cava or intraluminal vena caval tumor thrombectomy during retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and results. (1991) (37)
Rehabilitation in ankylosing spondylitis (2008) (37)
Detection of antisperm-antibodies in patients with primary testicular cancer. (1991) (37)
Advanced testicular cancer: update for urologists. (1998) (36)
Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT). (2003) (36)
The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. (1995) (36)
Malignant sex cord-stromal tumor of testis. (1984) (36)
The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. (1994) (35)
Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy? (1998) (35)
Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer. (1996) (35)
Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage a nonseminomatous testicular germ cell tumor at low risk for occult metastasis (1995) (34)
Percutaneous transluminal angioplasty for renal artery stenosis in a solitary functioning kidney. (1979) (34)
Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. (2005) (33)
Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. (1995) (32)
Malignant testicular neoplasms in immunosuppressed patients. (1996) (32)
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors (1994) (32)
Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors (1995) (31)
Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. (2000) (31)
Review of delayed orchiectomy in patients with disseminated testis tumors. (1983) (30)
Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy (1994) (29)
Angiomyolipoma: emerging concepts in management. (1982) (29)
Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma. (1995) (29)
cis-Platinum combination chemotherapy of bladder cancer: an update. (1979) (28)
Flow‐cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical‐stage‐I non‐seminomatous testicular germ‐cell tumors (1994) (28)
Bacterial endocarditis in chronic hemodialysis patients: a complication more common than previously suspected. (1971) (27)
Adrenalectomy via the dorsal approach: a benchmark for laparoscopic adrenalectomy. (1995) (26)
The multiple manifestations of neuroblastoma. (1974) (24)
Radiology in primary hyperaldosteronism. (1976) (24)
Chemotherapy for disseminated testicular cancer. (1977) (24)
The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy. (1996) (23)
A randomized , double-blind study of AMG 108 ( a fully human monoclonal antibody to IL-1 R 1 ) in patients with osteoarthritis of the knee (2011) (23)
Primary aldosteronism: pathophysiology, diagnosis and treatment. (1983) (23)
Management of retroperitoneal recurrences. Seminoma and nonseminoma. (1994) (23)
Occlusion of the artery to a solitary kidney. Restoration of renal function after prolonged anuria. (1974) (23)
Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor. (2005) (22)
Disseminated seminoma: re-evaluation of treatment protocols. (1981) (22)
Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer. (1996) (22)
Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results. (1986) (22)
Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release. (1977) (21)
Results of surgical treatment of renovascular hypertension. (1979) (21)
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery. (2007) (21)
Hepatic Resection for Disseminated Germ Cell Carcinoma (1990) (20)
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer. (1996) (20)
Retroperitoneal lymph node dissection in testicular cancer. (2007) (19)
Bilateral nephrectomy: its role in management of the malignant hypertension of end-stage renal disease. (1971) (18)
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome. (2007) (18)
Ureteroneocystostomy versus ureteropyelostomy: a comparison in the same renal allograft series. (1975) (18)
Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis (1994) (18)
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? (2005) (18)
Combined Urologic and Thoracic Approaches for Advanced or Disseminated Testis Cancer (1999) (17)
Incidental appendectomy during urological surgery. (1995) (17)
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism. (1983) (17)
Selecting initial therapy. Seminoma and nonseminoma (1987) (17)
Stage I nonseminomatous germ-cell testicular cancer — management options and risk-benefit considerations (1994) (17)
AN EVALUATION OF VOIDING CYSTOMETRY AS A DIAGNOSTIC TEST FOR BLADDER OUTLET OBSTRUCTION. (1964) (16)
Juxtaglomerular cells in renal angiomyolipoma. Ultrastructural observation. (1984) (15)
Renal vascular hypertension. Surgery vs. dilation. (1986) (15)
The Current Management of Neuroblastoma (1980) (15)
Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary? (1980) (15)
Bilateral Wilms tumors. (1978) (15)
Clinical stage I pure yolk sac tumor of the testis in adults has different clinical behavior than juvenile yolk sac tumor. (2000) (15)
Mucosal T Lymphocyte Numbers Are Selectively Reduced in Integrin αE (CD103)-Deficient Mice (1999) (15)
Advanced bladder cancer: therapy with cis-dichlorodiammineplatinum(II), adriamycin, and 5-fluorouracil. (1979) (14)
Hyperaldosteronism due to unsuspected adrenal carcinoma: discovery during investigation of hypertension in a young woman. (1981) (14)
What is the appropriate follow-up after treatment? (1996) (13)
Vascular considerations in postchemotherapy (1994) (13)
Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors? (2005) (13)
Retroperitoneal lymphadenectomy for clinical stage a testis cancer: Modifications of technique and impact on ejaculation (1994) (12)
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors. (2007) (12)
A preliminary report: postoperative fertility assessment in nerve-sparing RPLND patients. (1993) (12)
Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer (2004) (12)
Surgical treatment of clinical stage A nonseminomatous testis cancer. (1992) (11)
Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection (2004) (10)
Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy. (1991) (10)
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer. (1995) (10)
Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors (2006) (10)
High intensity focused ultrasound treatment of human BPH. (1994) (10)
Possible mechanism of hypoglycemia following removal of pheochromocytoma. (1980) (10)
Vascular considerations in postchemotherapy (1994) (10)
Sixteen-year survival with metastatic signet ring cell bladder carcinoma. (1980) (10)
Nerve-sparing retroperitoneal lymphadenectomy for testis cancer. Evolution of surgical templates for low-stage disease. (1993) (10)
Evolving concepts in surgical management of testis cancer. (1992) (10)
Post-chemotherapy resection of nonseminomatous germ cell testicular tumors metastatic to the mediastinum. (1996) (9)
Nerve-Sparing Retroperitoneal Lymphadenectomy for Testis Cancer (1993) (9)
Retroperitoneal lymphadenectomy: the anterior approach including bilateral suprarenal-hilar dissection. (1977) (9)
Micro-penis following Badenoch pull-through procedure: a case report. (1970) (8)
Testicular cancer: innovations in diagnosis and treatment. (1988) (8)
430: Is Full Bilateral Retroperitoneal Lymph Node Dissection (RPLND) Always Necessary for Post Chemotherapy Residual Tumor? (2005) (7)
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II. (1994) (6)
The role of retroperitoneal surgery in testis cancer. (2002) (6)
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava. (1994) (6)
Metastatic pathways of nonseminomatous germ cell tumors. (1984) (6)
Testicular cancer, clinical stage I. (1989) (5)
High-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. (1994) (5)
Testicular Cancer: The Indiana University Experience (1980) (5)
Surgery in advanced disease for testicular cancer. (1990) (4)
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy. (1995) (4)
Lymph Node Surgery in Urology (1995) (4)
Chemotherapy of bladder cancer with Cis-diammine-dichloroplatinum (DDP), adriamycin (ADR), and 5-fluorouracil (5-FU) (1978) (4)
Ureteral and bladder injuries in children. (1975) (4)
Acute Versus Chronic Experimental Hypertension: The Difference in Pressor Response to Partial Nephrectomy (1969) (4)
Recurrent testis cancer: seeding from retroperitoneal nodes after complete remissions by chemotherapy. (1983) (4)
Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997. (2002) (4)
Accelerated renal allograft rejection following blood transfusion. (1971) (3)
Retroperitoneal lymphadenectomy in staging and treatment of clinical stage I and II nonseminomatous testis cancer (NSGCT): the development of nerve-sparing techniques. (1996) (3)
Hypogandotropic hypogonadism with anosmia: the Kallmann syndrome. (1971) (3)
Metastatic renal embryoma: survival following therapy. (1967) (3)
Seminar article Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer (2005) (3)
Complications of retroperitoneal lymph node dissection. (1981) (3)
Hypogonadism in chromatin-negative phenotypic male subjects. (1970) (3)
Guest Editorial: Testicular Cancer (1981) (2)
LONG TERM MORBIDITY AND SURVIVAL IN PATIENTS UNDERGOING VENA CAVA RESECTION FOR METASTATIC GERM CELL TUMORS (1999) (2)
Biology of metastases and its clinical implications: testicular germ-cell tumors (2004) (2)
Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection (2004) (2)
591: Do Postchemotherapy Patients who Present with an Elevated Serum AFP and Pure Seminoma in the Orchiectomy Specimen Have a Higher Probability of Finding Necrosis only in the Retroperitoneal Lymph Node Dissection (RPLND) Specimen? (2006) (2)
RESULTS OF RETROPERITONEAL LYMPH NODE DISSECTION IN CLINICAL STAGE I PURE YOLK SAC TUMOR IN ADULTS (1999) (2)
Urologic neoplasia series. Cytoreductive surgery for metastatic testis cancer: considerations of timing and extent. (1979) (2)
Reproductive aspects of testicular germ cell cancer: general discussion. (1993) (2)
Correlation of clonogenic growth with histologic diagnosis after resection of residual tissue following chemotherapy for nonseminomatous testis cancer. (1989) (2)
Pheochromocytoma presenting as middeldorpf tumor: case report. (1978) (2)
Status of adjuvant therapy for renal cell cancer. (1979) (1)
Unsolved problems in testis cancer. (1993) (1)
Selection of patients for renal rehabilitation. (1972) (1)
NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTION (2000) (1)
Discordance between the site of primary nonseminomatous germ cell tumor of the testis and retroperitoneal metastatic disease secondary to anomalous venous drainage of the testis. (1996) (1)
Obscure abdominal distress and vascular collapse in a man. (1979) (1)
Development of Oakton Community College's Graduation/Registration/Advisement System (GRADS) and the Standards of Academic Progress (SOAP) Utilizing Computer Resources. (1984) (1)
Outcome Analysis for Patients with Persistent Non-Seminomatous Germ Cell Tumour in Post-Chemotherapy Retroperitoneal Lymph Node Dissections (1994) (1)
RECURRENCE PATTERN IN PATIENTS WITH NECROSIS ONLY AT POST CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND) (2008) (1)
[Nerve sparing retroperitoneal lymphadenectomy (RLA)]. (2010) (1)
Cytoreductive surgery in testicular cancer (1984) (1)
Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors (2004) (1)
Percutaneous transluminal dilatation or surgery in the management of renal vascular hypertension? (1981) (1)
The updated indiana university experience with nerve sparing rplnd: effective organ preserving therapy (1997) (1)
Observations on renal mass in experimental hypertension. (1966) (1)
Outcomes in Patients with Testicular Maldescent and Germ Cell Neoplasia: A Retrospective Assessment and Review of the Literature (2018) (1)
Testicular cancer. (1981) (1)
Book ReviewUrologic Surgery. (1969) (0)
In Reply: RE (1996) (0)
586: What is the Short-Term Morbidity of Primary Retroperitoneal Lymph Node Dissection in a Contemporary Group of Patients? (2006) (0)
Fertility in Nerve-Sparing RPLND (1994) (0)
Aortic Replacement in Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Cancer (1994) (0)
Results a nd O utcome o f R etroperitoneal L ymph N ode Dissection f or C linical S tage I E mbryonal Carcinoma-Predom inant T estis C ancer (2000) (0)
Retroperitoneal lymphadenectomy (RPLND) in low stage disease (staging RPLND) (one point of view). (1985) (0)
Risk Factors for Relapse in Teratoma Resected Postchemotherapy for Metastatic Testis Cancer (1987) (0)
DOES THE DURATION OF SYMPTOMS BEFORE ORCHIECTOMY PREDICT METASTATIC DISEASE IN PATIENTS PRESENTING WITH CLINICAL STAGE A NONSEMINOMATOUS GERM CELL TUMOR (2008) (0)
Re: Review of Delayed Orchiectomy in Patients with Disseminated Testis Tumors by, B. W. Snow, R. G. Rowland, J. P. Donohue, L. H. Einhorn and S. D. Williams, J. Urol., 129: 522–523, 1983 (1984) (0)
Clues to aetiology of testicular germ cell tumours from descriptive epidemiology. Discussion (1993) (0)
COMMENT ON: ADRENALECTOMY VIA THE DORSAL APPROACH : A BENCHMARK FOR LAPARASCOPIC ADRENALECTOMY. AUTHORS' REPLY (1996) (0)
A cure versus chronic experimental hypertension: the difference in pressor response to partial neophrectomy. (1969) (0)
Postchemotherapy: Radical Retroperitoneal Lymph Node Dissection (1999) (0)
Overview: treatment of local regional disease. (1990) (0)
Management of non-seminomatous testis cancer. (1983) (0)
Urological Survey: Abstracts: Diagnostic Urology and Testis CancerPostchemotherapy Retroperitoneal Lymph Node Dissection is Effective Therapy in Selected Patients With Elevated Tumor Markers After Primary Chemotherapy Alone (1998) (0)
The multiple manifestations of neuroblastoma. (1973) (0)
1176: Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor Receptor-3 as Predictors of Lymphatic Metastasis in Stage a Testis Cancer (2004) (0)
Indications and results of lymphadenectomy for testis cancer. (1984) (0)
The role of lymph node dissection in testicular cancer. (1990) (0)
Re: Editorial comment to monitoring of emission as direct intraoperative control for nerve sparing retroperitoneal lymphadenectomy. (1994) (0)
Surgery for testis cancer: a changing perspective. (1980) (0)
Indications and results of surgery after chemotherapy of testicular tumors (NSGT and seminoma). (1988) (0)
Impact of the preparation technique on DNA content measured by image analysis in early stage human testis cancer (2007) (0)
Evaluation of patients for secondary hypertension. (1979) (0)
Neovascularization in clinical stage I testicular germ cell tumor as a predictor of metastatic disease (2007) (0)
Secondary retroperitoneal lymph node dissection in the management of recurrent germ cell testicular tumors (1997) (0)
[Role of primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous testicular tumors]. (1991) (0)
Stage II nonseminomatous germ-cell testicular tumors — the Indiana experience and risk-benefit analysis (1994) (0)
Predictors of Residual Mass Histology Following Chemotherapy for Metastatic Nonseminomatous GCT: Univariate and Multivariate Meta-Analysis (1994) (0)
Aldosteronism updated. (1973) (0)
ANALYIS OF HIGH RESOLUTION SCROTAL US WITH PATHOLOGIC CORRELATION IN PATIENTS POST CHEMOTHERAPY FOR GERM CELL TUMOR (1989) (0)
In Reply: Re: Adrenalectomy Via the Dorsal Approach: A Benchmark for Laparoscopic Adrenalectomy (1996) (0)
Tissue typing for transplantation: a progress report. (1970) (0)
Desmoid tumors. (1987) (0)
Re: Why Retroperitoneal Lymphadenectomy for Testicular Tumors?, by w. L. Caldwell, J. Urol., 119: 754-758, 1978 (1979) (0)
Brain death and the case for en bloc cadaver nephrectomy (1975) (0)
Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up (2004) (0)
Re: why retroperitoneal lymphadenectomy for testicular tumors. (1979) (0)
Nerve-sparing post-chemotherapy rplnd (1997) (0)
ADRENAL SURGERY : Clinical Decision Making (1989) (0)
Treatment alternatives in advanced testicular cancer. (1985) (0)
[New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors]. (1995) (0)
Surgery for Germ Cell Tumours: Current Status in the USA (2002) (0)
Development of a transplantation team in Indiana. I. (1971) (0)
926: Impact of the Number of Positive Lymph Nodes on Disease Free Survival (DFS) for Patients with Pathologic Stage B1 Nonseminomatous Germ Cell Tumor (NSGCT) (2004) (0)
Detection of minimal tumor load in early stage nonseminomatous germ cell testicular tumors (NSGCT) (2007) (0)
Treatment of local regional disease. (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John Patrick Donohue?

John Patrick Donohue is affiliated with the following schools: